These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery]. Xu JX; Tang JB; Zhao LH; Shen YQ Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464 [TBL] [Abstract][Full Text] [Related]
6. Polymer-drug conjugates: recent progress on administration routes. Pang X; Yang X; Zhai G Expert Opin Drug Deliv; 2014 Jul; 11(7):1075-86. PubMed ID: 24758250 [TBL] [Abstract][Full Text] [Related]
7. Acid-degradable polymers for drug delivery: a decade of innovation. Binauld S; Stenzel MH Chem Commun (Camb); 2013 Mar; 49(21):2082-102. PubMed ID: 23320254 [TBL] [Abstract][Full Text] [Related]
8. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Ge Z; Liu S Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663 [TBL] [Abstract][Full Text] [Related]
9. Polymer-drug conjugates: present state of play and future perspectives. Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841 [TBL] [Abstract][Full Text] [Related]
10. Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery. Liu Z; Wang Y; Zhang N Expert Opin Drug Deliv; 2012 Jul; 9(7):805-22. PubMed ID: 22607499 [TBL] [Abstract][Full Text] [Related]
11. Polymer-drug conjugates: current status and future trends. Greco F; Vicent MJ Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750 [TBL] [Abstract][Full Text] [Related]
15. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282 [TBL] [Abstract][Full Text] [Related]
16. Smart linkers in polymer-drug conjugates for tumor-targeted delivery. Chang M; Zhang F; Wei T; Zuo T; Guan Y; Lin G; Shao W J Drug Target; 2016; 24(6):475-91. PubMed ID: 26560242 [TBL] [Abstract][Full Text] [Related]
17. Role of polymer-drug conjugates in organ-specific delivery systems. Paramjot ; Khan NM; Kapahi H; Kumar S; Bhardwaj TR; Arora S; Mishra N J Drug Target; 2015 Jun; 23(5):387-416. PubMed ID: 25720345 [TBL] [Abstract][Full Text] [Related]
18. Classification of stimuli-responsive polymers as anticancer drug delivery systems. Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737 [TBL] [Abstract][Full Text] [Related]
19. Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications. Bazban-Shotorbani S; Hasani-Sadrabadi MM; Karkhaneh A; Serpooshan V; Jacob KI; Moshaverinia A; Mahmoudi M J Control Release; 2017 May; 253():46-63. PubMed ID: 28242418 [TBL] [Abstract][Full Text] [Related]
20. Polymeric anticancer drugs with pH-controlled activation. Ulbrich K; Subr V Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]